MCT2D

Name: MCT2D
Author: University of Michigan

University of Michigan

DOCUMENTED

Published in academic literature

For:Clinicians & Healthcare ProfessionalsGeneral Public & EnthusiastsPatients & Caregivers

Free

Download on the App Store Get it on Google Play

App Summary

The MCT2D app provides clinicians and patients in Michigan with tools and resources, such as a medication coverage checker, to support a statewide initiative aimed at improving guideline-based care for type 2 diabetes. The associated research describes the development of this statewide collaborative, which established a quality improvement network including data from an initial sample of 96,140 patients with T2D. The authors conclude this collaborative approach is a promising opportunity to accelerate the adoption of guideline-concordant care and may serve as a model for other regions.

App Screenshots

Detailed Description

Functionality & Mechanism

Developed by the Michigan Collaborative for Type 2 Diabetes (MCT2D), the system disseminates clinical resources and information supporting guideline-concordant care. Its interface features a 'Coverage Checker' module that details insurance formulary data for specific diabetes pharmacotherapies within Michigan. A separate module provides a filterable library of provider and patient resources focused on continuous glucose monitoring, medication management, and diet. The application also delivers news and event information from the collaborative quality initiative.

Evidence & Research Context

The app is a component of MCT2D, a statewide collaborative quality initiative (CQI) designed to accelerate the adoption of guideline-concordant care for type 2 diabetes.
The associated research describes the initiative's implementation across 28 physician organizations and 336 constituent practices throughout Michigan.
Baseline data from the initiative's patient cohort (N=96,140) indicated 64.8% of individuals had a BMI ≥30.0, establishing the clinical context for quality improvement efforts.
The collaborative's primary targets, supported by the app's resources, include increasing the use of guideline-directed pharmacotherapy and evidence-based continuous glucose monitoring.

Intended Use & Scope

This tool is intended for clinicians and patients in Michigan participating in or served by the MCT2D quality initiative. Its primary utility is as a clinical reference and educational resource to facilitate access to information. The application does not provide medical advice or treatment recommendations; all clinical decisions require consultation with a qualified healthcare provider.

Studies & Publications

1 publication

Peer-reviewed research associated with this app.

Development/Design Paper

The Michigan Collaborative for Type 2 Diabetes (MCT2D): Development and implementation of a statewide collaborative quality initiative

Oshman et al. (2024) · BMC Health Services Research

Describes the research-driven development of this app

Abstract Background Type 2 diabetes (T2D) is one of the most prevalent chronic diseases worldwide and a leading cause of cardiorenal disease and mortality. Only one-third of individuals with T2D receive care as recommended by the American Diabetes Association's clinical practice guidelines. Effective strategies are needed to accelerate the implementation of guideline concordant T2D care. Methods The Michigan Collaborative for Type 2 Diabetes (MCT2D) is a statewide population health collaborative quality initiative (CQI) developed to improve the care of all people with T2D in Michigan. MCT2D has developed a learning health system with physician organizations and their constituent practices to support quality improvement initiatives focused on (1) improving use of guideline-directed pharmacotherapy to improve cardiorenal outcomes, (2) increasing evidence-based use of continuous glucose monitoring, and (3) supporting use of lower carbohydrate eating patterns. Results Between 2021 and 2022, MCT2D recruited 28 of the 40 Michigan-based physician organizations participating in Blue Cross' Physician Group Incentive Program with 336 constituent practices and 1357 physicians in primary care (304), endocrinology (21) and nephrology (11). In January 2022, baseline data included a sample of 96,140 unique individuals with T2D. The baseline HbA1c was ≤ 7.0% for 66.3% of patients (n = 32,787), while 14.9% of patients had a most recent HbA1c ≥ 8.0% (n = 7,393). The most recent body mass index (BMI) was ≥ 30.0 for 64.8% of patients (n = 38,516). Discussion MCT2D has organized a statewide collaborative to recruit and engage a diverse and large set of physician organizations and their constituent practices. This is a promising opportunity to accelerate adoption of guideline-concordant care for people with T2D and may be a model for other state or regional collaboratives. Future directions include specific evidence-based interventions targeted at reducing diabetes-linked comorbidities and associated healthcare costs as well as strategies focused on T2D prevention among at-risk populations.

In the Media

MCT2D

The Michigan Collaborative for Type 2 Diabetes (MCT2D) developed a comprehensive platform to shift the paradigm of type 2 diabetes care through dissemination of best practices and partnering to remove barriers to care. The initiative brings together nearly 350 primary care, endocrinology, and nephrology practices as well as patient advisors from across Michigan to collectively advance evidence-based diabetes care. MCT2D receives support from Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.

Mct2dRead article

MCT2D

The Michigan Collaborative for Type 2 Diabetes (MCT2D) developed a platform to improve Type 2 diabetes care through collaborative learning and advocacy initiatives. Blue Cross Blue Shield of Michigan provides support for MCT2D as part of the BCBSM Value Partnerships program. The platform hosts regular events including Patient Advisory Board meetings and learning community sessions on specialized topics like MASLD guidelines for people with diabetes.

Mct2dRead article

MCT2D Mobile App Available

The Michigan Collaborative for Type 2 Diabetes (MCT2D) launched the MCT2D mobile app to support diabetes management, with backing from Blue Cross Blue Shield of Michigan through their Value Partnerships program. The collaborative receives ongoing support from BCBSM, though the organizations maintain that expressed viewpoints may differ between the partners. The app became available as of August 12, 2025.

Mct2dRead article